The validation of key targets using the GEPIA2 and HPA databases revealed significantly higher expressions of AKT1, IL6, and SRC in PAAD tissues compared to normal pancreatic tissues. This evidence concerns the gene AKT1 and pancreatic adenocarcinoma.